Kotahitanga 8
Impact of point of care testing on length of stay of patients in the Emergency Department. We were surprised by the non significant reduction in ED length of stay and curious about the possibility of entrenched clinical work patterns. Being a centre without CT we were also excited about...
empagliflozin
Great Goodfellow webinar tonight. Endocrinologist Dr Ryan Paul and RNZCGP Medical Director Dr Bryan Betty discussed the role of these medications. Key Messages Empagliflozin is a preferred 2nd line agent in cardiovascular disease, especially heart failure, and renal disease. It reduces mortality from cardiovascular events and renal disease progression...
Of Art and Uncertainty
“In order to make progress, one must leave the door to the unknown ajar.” Richard Feynman...